Biography
Dr Emil Gustavsson’s research combines genetics and transcriptomics to understand the molecular basis of Parkinson’s and Alzheimer’s disease. He completed his PhD in Medical Genetics at the University of British Columbia under Prof. Matt Farrer, followed by postdoctoral training at UBC’s Centre for Applied Neurogenetics. He later joined University College London, working with Prof. Mina Ryten and Prof. Sir John Hardy, where he began applying long-read sequencing to characterise disease-associated genes, work partly supported by a BrightFocus Fellowship in Alzheimer’s disease.
Dr Gustavsson now uses long-read DNA and RNA sequencing, computational transcriptomics, and proteogenomics to investigate transcript diversity in neurodegeneration and to determine how genetic variants influence the expression, and function of specific transcripts. His group aims to define transcript diversity at key disease loci and use these insights to uncover mechanisms and guide the development of precise RNA-based interventions.
News
